[PDF][PDF] Employing metabolism to improve the diagnosis and treatment of pancreatic cancer

CJ Halbrook, CA Lyssiotis - Cancer cell, 2017 - cell.com
Pancreatic ductal adenocarcinoma is on pace to become the second leading cause of
cancer-related death. The high mortality rate results from a lack of methods for early …

Current methods to define metabolic tumor volume in positron emission tomography: which one is better?

HJ Im, T Bradshaw, M Solaiyappan, SY Cho - Nuclear medicine and …, 2018 - Springer
Numerous methods to segment tumors using 18 F-fluorodeoxyglucose positron emission
tomography (FDG PET) have been introduced. Metabolic tumor volume (MTV) refers to the …

Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics

RD Seban, JS Nemer, A Marabelle, R Yeh… - European journal of …, 2019 - Springer
Purpose An imaging-based stratification tool is needed to identify melanoma patients who
will benefit from anti Programmed Death-1 antibody (anti-PD1). We aimed at identifying …

[HTML][HTML] Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer

Y Toyama, M Hotta, F Motoi, K Takanami… - Scientific reports, 2020 - nature.com
Patients with pancreatic cancer have a poor prognosis, therefore identifying particular tumor
characteristics associated with prognosis is important. This study aims to investigate the …

[HTML][HTML] The role of imaging in current treatment strategies for pancreatic adenocarcinoma

H Rhee, MS Park - Korean Journal of Radiology, 2021 - ncbi.nlm.nih.gov
In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability
evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk …

Prognostic factors in patients treated with 223Ra: the role of skeletal tumor burden on baseline 18F-fluoride PET/CT in predicting overall survival

EC Etchebehere, JC Araujo, PS Fox… - Journal of Nuclear …, 2015 - Soc Nuclear Med
The purpose of this study was to evaluate outcome after 223Ra dichloride therapy (223Ra)
and to determine whether skeletal tumor burden on whole-body 18F-fluoride PET/CT can be …

Intratumoral heterogeneity of 18F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma

SH Hyun, HS Kim, SH Choi, DW Choi, JK Lee… - European journal of …, 2016 - Springer
Purpose To assess whether intratumoral heterogeneity measured by 18 F-FDG PET texture
analysis has potential as a prognostic imaging biomarker in patients with pancreatic ductal …

The role of 18F-FDG PET/CT and PET/MRI in pancreatic ductal adenocarcinoma

R Yeh, L Dercle, I Garg, ZJ Wang, DM Hough… - Abdominal …, 2018 - Springer
Pancreatic ductal adenocarcinoma (PDAC) remains a difficult disease to treat and continues
to portend a poor prognosis, as most patients are unresectable at diagnosis. 18F …

Magnetic nanoparticle hyperthermia for treating locally advanced unresectable and borderline resectable pancreatic cancers: The role of tumor size and eddy-current …

A Attaluri, SK Kandala, H Zhou, M Wabler… - International Journal …, 2020 - Taylor & Francis
Purpose Tumor volume largely determines the success of local control of borderline
resectable and locally advanced pancreatic cancer with current therapy. We hypothesized …

[HTML][HTML] Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics

H Xing, Z Hao, W Zhu, D Sun, J Ding, H Zhang, Y Liu… - EJNMMI research, 2021 - Springer
Purpose To develop and validate a machine learning model based on radiomic features
derived from 18 F-fluorodeoxyglucose (18 F-FDG) positron emission tomography/computed …